Whalegun
Home

Kevin Charles Gorman, CEO: Neurocrine Biosciences NBIX Sell · Filed 23/08/23

Trade details

Type
Insider sale
Amount
$1,001,827.2
Shares · price
9,328 sh · $107.40 a share
Held after
499,754 sh
Stock
Neurocrine Biosciences NBIX
Person
Kevin Charles GormanCEO
Trade date
23/08/21
Filed
23/08/23
Days to filing
2 days

Sold 1.8% of holdings

Share of holding sold
1.8%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 23/07/22~23/09/20

Kevin Charles Gorman's recent trades

  • Kevin Charles Gorman

    Sell10b5-1 planXencor

    $92.7K

    Filed 06/17

  • Kevin Charles Gorman

    Planned sale10b5-1 planXencor

    $92.7K

    Filed 06/15

  • Kevin Charles Gorman

    Sell10b5-1 planNeurocrine Biosciences

    $37.8M

    Filed 05/21

  • Kevin Charles Gorman

    Planned sale10b5-1 planNeurocrine Biosciences

    $38.5M

    Filed 05/19

  • Kevin Charles Gorman

    Sell10b5-1 planNeurocrine Biosciences

    $13.4M

    Filed 25/08/11

Kevin Charles Gorman, CEO — sold $1M of Neurocrine Biosciences NBIX · 1.8% of holdings · 10b5-1 plan | Whalegun